News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Aging | Epigenetic Age and Lung Cancer Risk in the CLUE II Prospective Cohort Study

Aging

February 16, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 3, entitled, “Epigenetic age and lung cancer risk in the CLUE II prospective cohort study.” continue reading »

Aging | Immune-mediated Platelet Depletion Augments Alzheimer’s Disease in Mice

Aging

February 15, 2023
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 15, Issue 3, entitled, “Immune-mediated platelet depletion augments Alzheimer’s disease neuropathological hallmarks in APP-PS1 mice.” continue reading »

Oncotarget | Novel Prognostic Index to Predict Survival Outcomes in Gastric Cancer Patients

News

February 14, 2023
PRESS RELEASE: On January 31, 2023, researchers from Shimane University and Matsue Red Cross Hospital published a new research paper in Oncotarget, entitled, “Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer.” continue reading »

Genes & Cancer | CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens

Genes & Cancer

February 10, 2023
PRESS RELEASE: A new review was published in Genes & Cancer on February 1, 2023, entitled, “CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens.” continue reading »

Oncotarget | Everolimus Inhibits Angiogenesis and Lymphangiogenesis in TP53 Mutant HNSCC by Downregulating STAT3/HIF-1α/VEGF Pathway

News

February 9, 2023
PRESS RELEASE: On February 2, 2023, a new research paper was published in Oncotarget, entitled, “Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC).” continue reading »